Univest
Univest
  • Markets
  • Aarti Drugs Analyst Review 2027: Record Quarter, Profit Up 83% and a P/E Half the Industry’s

    • November 17, 2026
    • Posted by: Chaitanya Auti
    • Category: Market
    No Comments
    Aarti Drugs Analyst Review 2027: Record Quarter, Profit Up 83% and a P/E Half the Industry's

    Aarti Drugs posted its highest-ever quarterly revenue, EBITDA and profit in Q2 FY27, with profit up 83% on better API pricing. It still trades at about 20 times earnings. We cover the business, margins, volume gap and 2027 triggers.

    read more